이창한, CHANG-HAN LEE, Ph.D.
Assistant Professor
Department of Pharmacology at Seoul National University College of Medicine
Department of Biomedical Sciences at Seoul National University College of Medicine
SNU Hospital
SNU Dementia Research Center
SNU Bio-Max Institute
Wide River Institute of Immunology (WRII) SNU
Office: #614 at Basic Science Research Building
Lab: #423 at Basic Science Research Building
Email: chlee-antibody@snu.ac.kr
Dr. Lee has studied the protein and antibody engineering. My main researches include 1) non-antibody protein scaffold based on Kringle domain, 2) engineering and discovery of antibody Fab domain to obtain antigen-binding activity, and 3) engineering of antibody Fc domain to study the immune response of antibodies or/and to maximize the therapeutic efficacy of antibodies by improving pharmacokinetics of antibody.
Education
Bachelor: Dept. of Chemical and Biological Engineering, Ajou University (2000.03-2007.02)
Ph.D: Dept. of Molecular Science and Technology, Ajou University (2007.03-2013.02), Advisor: Dr. Yong-Sung Kim (http://antibody.ajou.ac.kr/)
Experience
Postdoctoral research fellow: Dept of Chemical Engineering, The University of Texas at Austin (2013.03-2018.02),
Advisor: Dr. George Georgiou (http://www.che.utexas.edu/georgiou/index.html)
Research associate: Dept of Chemical Engineering, The University of Texas at Austin (2018.03-2020.02)
Career
Assistant Professor: Dept. of Pharmacology, Seoul National University College of Medicine (2020.03-)
Member of SNU Dementia Research Center (2020.05-) (http://snuadrc.com/)
SNU 10-10 project CDMC (http://cdbc.snu.ac.kr/bbs/board.php?bo_table=sub6_1_a)
SNU Bio-Max Institute 운영위원 (http://bio-max.snu.ac.kr/) (2021.05~)
서울대학교 의과대학 의학교육실 담당 교수 (2022.01~2023.12)
서울대학교 의과대학 연구진흥위원회 위원 (2022.01~2023.12)
Review editor
Frontiers in Immunology (2021.03-)
Frontiers in Bioengineering and Biotechnology (2021.04-)
Protein Science (2021.04-)
Signal Transduction and Targeted Therapy (2022.02-)
대한암예방학회 학술위원회 위원 (2021.01-)